Évolution de la sensibilité aux quinolones et aux fluoroquinolones des bacilles à Gram négatif aérobies isolés dans un hôpital universitaire (1992–2000)

Dornbusch, 1990, Resistance to beta-lactam antibiotics and ciprofloxacin in gram-negative bacilli and staphylococci isolated from blood: a European collaborative study, J Antimicrob Chemother, 26, 269, 10.1093/jac/26.2.269 Kresken, 1994, Prevalence of fluoroquinolone resistance in Europe, Infection, 22, S90, 10.1007/BF01793572 Kresken, 1988, Development of resistance to nalidixic acid and the fluoroquinolones after the introduction of norfloxacin and ofloxacin, Antimicrob Agents Chemother, 32, 1285, 10.1128/AAC.32.8.1285 Segreti, 1995, Effect of quinolone use on antimicrobial susceptibility patterns over a 5-year period, Drugs, 49, 185, 10.2165/00003495-199500492-00035 Chin, 1989, Resistance to ciprofloxacin appearing during therapy, Am J Med, 87, 28S, 10.1016/0002-9343(89)90015-6 Ena, 1998, Emergence of ciprofloxacin resistance in Escherichia coli isolates after widespread use of fluoroquinolones, Diagn Microbiol Infect Dis, 30, 103, 10.1016/S0732-8893(97)00216-2 Goettsch, 2000, Increasing resistance to fluoroquinolones in Escherichia coli from urinary tract infections in the Netherlands, J Antimicrob Chemother, 46, 223, 10.1093/jac/46.2.223 2000, Communiqué 2001–2001, Pathol Biol, 48, 832 Hejblum, 1993, Automated interpretation of disk diffusion antibiotic susceptibility tests with the radial profile analysis algorithm, J Clin Microbiol, 31, 2396, 10.1128/JCM.31.9.2396-2401.1993 Hernandez, 2000, Trends in the susceptibilities of Proteus mirabilis isolates to quinolones, J Antimicrob Chemother, 45, 407, 10.1093/jac/45.3.407 Hoban, 1995, Canadian ofloxacin susceptibility study: a comparative study from 18 medical centers, Chemotherapy, 41, 34, 10.1159/000239321 Jones, 1992, Ofloxacin, a new broad spectrum fluoroquinolone. Results from a multicenter national comparative activity surveillance study, Diagn Microbiol Infect Dis, 15, 425, 10.1016/0732-8893(92)90084-7 Blumberg, 1995, Ciprofloxacin resistance among nosocomial Pseudomonas aeruginosa and Staphylococcus aureus in the United States, Infect Control Hosp Epidemiol, 16, 620, 10.2307/30141110 Chow, 1989, Cross-resistance of Pseudomonas aeruginosa to ciprofloxacin, extended-spectrum beta-lactams, and aminoglycosides and susceptibility to antibiotic combinations, Antimicrob Agents Chemother, 33, 1368, 10.1128/AAC.33.8.1368 Thomson, 1999, The global epidemiology of resistance to ciprofloxacin and the changing nature of antibiotic resistance: a 10 year perspective, J Antimicrob Chemother, 43, 31, 10.1093/jac/43.suppl_1.31 Tillotson, 1997, Fluoroquinolone resistance: mechanisms and epidemiology, J Med Microbiol, 46, 457 Garau, 1999, Emergence and dissemination of quinolone-resistant Escherichia coli in the community, Antimicrob Agents Chemother, 43, 2736, 10.1128/AAC.43.11.2736 Perez-Trallero, 1993, Ten-Year survey of quinolone resistance in Escherichia coli causing urinary tract infections, Eur J Clin Microbiol Infect Dis, 12, 349, 10.1007/BF01964432 Muder, 1991, Association with prior fluoroquinolone therapy of widespread ciprofloxacin resistance among gram-negative isolates in a Veterans Affairs medical center, Antimicrob Agents Chemother, 35, 256, 10.1128/AAC.35.2.256 Ogle, 1988, Development of resistance in Pseudomonas aeruginosa to imipenem, norfloxacin, and ciprofloxacin during therapy: proof provided by typing with a DNA probe, J Infect Dis, 157, 743, 10.1093/infdis/157.4.743 Kern, 1994, Emergence of fluoroquinolone-resistant Escherichia coli at a cancer center, Antimicrob Agents Chemother, 38, 681, 10.1128/AAC.38.4.681 Jarlier, 1996, Antibiotic susceptibility in aerobic gram-negative bacilli isolated in intensive care units in 39 French teaching hospitals (ICU study), Intens Care Med, 22, 1057, 10.1007/BF01699228 Vatopoulos, 1999, Bacterial Resistance to Ciprofloxacin in Greece: results from the National Electronic Surveillance System, Emerg Infect Dis [serial online], 5, 471, 10.3201/eid0503.990325 Cavallo, 2000, Antibiotic susceptibility and mechanisms of beta-lactam resistance in 1310 strains of Pseudomonas aeruginosa: a french multicentre study (1996), J Antimicrob Chemother, 46, 133, 10.1093/jac/46.1.133 Blondeau, 1998, Canadian Pseudomonas aeruginosa susceptibility study from 48 medical centers: focus on ciprofloxacin, Int J Antimicrob Agents, 10, 297, 10.1016/S0924-8579(98)00049-1 Hanberger, 1999, Antibiotic susceptibility among aerobic gram-negative bacilli in intensive care units in 5 European countries, JAMA, 281, 67, 10.1001/jama.281.1.67 Horrevorts, 1997, Development of resistance to ciprofloxacin in Acinetobacter baumannii strains isolated during a 20-month outbreak, J Antimicrob Chemother, 40, 460, 10.1093/jac/40.3.460 Tankovic, 1994, Characterization of a hospital outbreak of imipenem-resistant Acinetobacter baumannii by phenotypic and genotypic typing methods, J Clin Microbiol, 32, 2677, 10.1128/JCM.32.11.2677-2681.1994